Back to School: How biopharma can reboot drug development. Access exclusive analysis here
NTII partner Merz + Co. GmbH & Co. (Frankfurt, Germany) said that Memantine significantly
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury